GLP ‐1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta‐Analysis
Diabetes, Obesity and Metabolism · 2026-08 · 28 (8) · 6735-6743
DOI: 10.1111/dom.70864 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 11.05.2026. Verfasst von Cynthia F X C A Silva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology, Department of Pediatrics, Northwell Health, New York, New York, USA. Hauptthemen laut MEDLINE: Depression, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Aims
To assess the association between GLP‐1 receptor agonists (GLP‐1 RAs) and psychiatric outcomes in adolescents. Materials and Methods We conducted a systematic review and meta‐analysis following PRISMA 2020 guidelines. We searched PubMed, EMBASE and the Cochrane Library. We included randomized controlled trials (RCTs) and observational cohort studies of adolescents that compared GLP‐1 RAs prescribed for overweight, obesity or type 2 diabetes with placebo, no treatment or standard of care. We assessed suicidal ideation, suicide attempts and depression. We pooled risk ratios with 95% confidence intervals (CIs). We assessed heterogeneity with I 2 and χ 2 and used sensitivity and subgroup analyses to test robustness of our data. We assessed risk of bias using RoB 2 (randomized trials) and ROBINS‐I (observational studies) tools. We graded the certainty of evidence using the GRADE framework.
Results
We included 11 studies (9 RCTs, n = 1253; 2 observational, n = 8922; total n = 10 175). GLP‐1 RAs were associated with a lower risk of suicidal ideation versus control (RR 0.73; 95% CI: 0.54–0.99; p = 0.046; I 2 = 0%). We found no significant effects versus control on suicide attempts (RR 0.66; 95% CI: 0.16–2.61; p = 0.444; I 2 = 0%) or depressive symptoms (RR 0.73; 95% CI: 0.36–1.48; p = 0.282; I 2 = 50.4%).
Conclusions
GLP‐1 RAs were not associated with higher rates of suicidal behaviour or depression in adolescents. Pooled analysis suggested a possible lower risk of suicidal ideation, although this finding should be interpreted cautiously.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Endocrinology, Department of Pediatrics, Northwell Health, New York, New York, USA.
- Department of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil.
- Department of Medicine, Pontifical Catholic University of São Paulo, Sorocaba, São Paulo, Brazil.
- Department of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
- Department of Medicine, Federal University of Campina Grande, Cajazeiras, Paraíba, Brazil.
- Department of Psychiatry, University of Texas Southwestern, Dallas, Texas, USA.
ORCID-Profile: Cynthia F X C A Silva, Bruno Lins de Souza, Gianlucca Thomazini, Jardeson Júnior, Oscar Inácio de Mendonça Bisneto, Izabella de Abreu, Tulio Konstantyner, Marconi Abreu
Zitieren
APA
Silva, C. F. X. C. A., de Souza, B. L., Thomazini, G., Júnior, J., de Mendonça Bisneto, O. I., de Abreu, I., Konstantyner, T., & Abreu, M. (2026). GLP ‐1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta‐Analysis. Diabetes, Obesity and Metabolism, 28(8), 6735-6743. https://doi.org/10.1111/dom.70864
Vancouver
Silva CFXCA, de Souza BL, Thomazini G, Júnior J, de Mendonça Bisneto OI, de Abreu I, et al. GLP ‐1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta‐Analysis. Diabetes, Obesity and Metabolism. 2026;28(8):6735-6743. doi:10.1111/dom.70864
BibTeX
@article{Silva2026,
author = {Silva, Cynthia F X C A and de Souza, Bruno Lins and Thomazini, Gianlucca and Júnior, Jardeson and de Mendonça Bisneto, Oscar Inácio and de Abreu, Izabella and Konstantyner, Tulio and Abreu, Marconi},
title = {GLP ‐1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta‐Analysis},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {8},
pages = {6735--6743},
doi = {10.1111/dom.70864}
}
EUVIMED